Find information on Industry Analysis Report

TechNavio’s analysts forecast the Global Central Nervous System Drugs market to grow at a CAGR of -3.2 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increasing size of aging population. The Global EEG/EMG Equipment market has also been witnessing the trend of novel molecules, launched to treat central nervous system disorders effectively. However, patent expiration of key drugs could pose a challenge to the growth of this market.

The Global Central Nervous System Drugs Market 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Central Nervous System Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors dominating this market space include AstraZeneca plc, Eli Lilly & Co., Johnson & Johnson Ltd., and Pfizer Inc. Other vendors mentioned in the report: Abbott Laboratories, Sanofi S.A., Bristol-Myers Squibb Co., Eisai Co. Ltd., UCB Pharma, Merck & Co. Inc., Schering-Plough Corp., Shire plc, and Cephalon Inc.

Key questions answered in this report:
What will the market size be in 2015 and at what rate will it grow?
What key trends is this market subject to?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the opportunities and threats faced by each of these key vendors?
What are the strengths and weaknesses of each of these key vendors?

Table of Contents
01. Executive Summary
02. Introduction
03. Market Coverage
Product Offerings
04. Market Landscape
Global Central Nervous System Drugs Market
Market Size
Key Market Segments
04.1 Global Antipsychotics Market
04.2 Global Antidepressants Market
04.3 Global Antiepileptic Drugs Market
04.4 Global Anti-Alzheimer’s Drugs Market
04.5 Global ADHD Drugs Market
04.6 Global Hypnotics Market
04.7 Global Anti-Parkinson’s Drugs Market
04.8 Global Antimigraine Drugs Market
Segmentation of Global Central Nervous System Drugs Market
Five Forces Analysis
05. Geographical Segmentation
06. Key Leading Countries
07. Rate of Incidence and Prevalence
08. Vendor Landscape
Matrix of the Product Portfolio Matrix
Vendor Landscape of the Leading CNS Drugs Market Segments
08.1 Global Antipsychotics Market Segment
08.2 Global Antidepressants Market Segment
08.3 Global Antiepileptic Drugs Market Segment
09. Buying Criteria
10. Market Growth Drivers
11. Drivers and their Impact
12. Market Challenges
13. Impact of Drivers and Challenges
14. Market Trends
15. Key Vendor Analysis
15.1 Eli Lilly and Co.
Business Overview
SWOT Analysis
15.2 Pfizer Inc.
Business Overview
SWOT Analysis
15.3 AstraZeneca plc
Business Overview
SWOT Analysis
15.4 Johnson and Johnson Ltd.
Business Overview
SWOT Analysis
16. Other Reports in this Series

For more information kindly visit :
Global Central Nervous System Drugs Market 2011-2015


Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Fax: + 91 22 27812290
Follow us on twitter:!/Sandhya3B
Our Blogs:


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

Tag Cloud

%d bloggers like this: